Use of a Fibrin Sealant Patch at Cesarean for Conservative Management of Morbidly Adherent Placenta

Abstract

Background Morbidly adherent placenta represents a surgical challenge and source of maternal morbidity and mortality. We report the use of a fibrin sealant patch to address hemorrhage associated with a morbidly adherent placenta during cesarean delivery.

Case A patient underwent repeat cesarean delivery with complete anterior placenta previa and anticipated morbidly adherent placenta. Bleeding persisted following delivery and removal of the placenta, despite uterine artery embolization. A fibrin sealant patch was applied as an adjuvant intervention to the placental bed and hemostasis was achieved without resorting to a hysterectomy.

Conclusion Postpartum hemorrhage is an ongoing leading source of maternal morbidity and mortality. A case is presented in which a fibrin sealant patch provided control of focal placental bed bleeding, allowing removal of a focal morbidly adherent placenta and avoidance of hysterectomy.

Keywords

fibrin patch - placenta accrete - morbidly adherent placenta - postpartum hemorrhage - cesarean

• References

• 1 Bailit JL, Grobman WA, Rice MM. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015; 125 (03) 683-689
• 2 Perez-Delboy A, Wright JD. Surgical management of placenta accreta: to leave or remove the placenta?. BJOG 2014; 121 (02) 163-169 , discussion 169–170
• 3 Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E. ; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet 2018; 140 (03) 291-298
• 4 Evarrest Fibrin Sealant Patch: prescribing information. 2017 . Available from: https://hostedvl106.quosavl.com/qb/doc/n9kjvl0hvn14pei0kgrktcibp8 . Accessed April 21, 2018
• 5 Fuglsang K, Petersen LK. New local hemostatic treatment for postpartum hemorrhage caused by placenta previa at cesarean section. Acta Obstet Gynecol Scand 2010; 89 (10) 1346-1349
• 6 Shirata I, Fujiwaki R, Takubo K, Shibukawa T, Sawada K. Successful continuation of pregnancy after repair of a midgestational uterine rupture with the use of a fibrin-coated collagen fleece (TachoComb) in a primigravid woman with no known risk factors. Am J Obstet Gynecol 2007; 197 (04) e7-e9
• 7 Tinelli A. Post-cesarean section hemorrhage treated by a collagen patch coated with the human coagulation factors. J Clin Case Rep 2011; 1 (01) 1-4
• 8 TachoSil Fibrin Sealant Patch: full prescribing information. 2015 . Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM207483.pdf. Accessed April 21, 2018